|
| |
BioPortfolio's Approved Drugs DatabaseRenagelSevelamer HydrochlorideDownload PDF containing detailed information.
Press Releases About Renagel:
|
 |
| Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today |
7th October, 2009 |
|
DUBLIN, October 7 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announces the publication in Clinical
Nephrology of findings from a head-to
|
| BioTrends Releases TreatmentTrends(TM): US Nephrology, an Ongoing Syndicated Publication Providing Insight into Physician Perceptions and Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism |
12th January, 2009 |
BioTrends Research Group, Inc. |
EXTON, Pa., Jan. 12 /PRNewswire/ -- BioTrends Research Group, Inc. released TreatmentTrends(TM): US Nephrology, a syndicated report based on online survey results from 305 Nephrologists in the US.
|
| BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism |
27th October, 2008 |
BioTrends Research Group, Inc. |
EXTON, Pa., Oct. 27 /PRNewswire/ -- BioTrends Research Group, Inc.
released two new Nephrology TreatmentTrends(TM) publications based on survey
results from 204 Nephrologists and 201 Renal
|
| BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism |
25th July, 2008 |
BioTrends Research Group, Inc. |
EXTON, Pa., July 25 /PRNewswire/ -- BioTrends Research Group, Inc.
released its 10th quarterly Nephrology TreatmentTrends(TM) publication, a
syndicated report offering comprehensive insight into
|
| Genzyme Reports Strong Second-Quarter Growth |
23rd July, 2008 |
Genzyme Corporation |
CAMBRIDGE, Mass., July 23 /PRNewswire-FirstCall/ -- Genzyme Corporation
(Nasdaq: GENZ) today reported strong sales and profit growth in the second
quarter, along with significant progress in its
|
Companies working in the area of Renagel from Bioportfolio's Biocorporate database : | |
| Company Name | |
We are dedicated to having a positive effect on the lives of people living with illness and disease. We have demonstrated this by bringing important new therapies from discovery to market. GelTex’s...
www.geltex.com/ View full profile
| |
GelTex Pharmaceuticals, Inc. is developing non-absorbed, polymer-based pharmaceuticals that selectively bind to andeliminate target substances from the intestinal tract. In October 1998, the Company...
www.geltex.com/ View full profile
| |
This page has been viewed 41 times
Recent Search Terms used to find this page: Secondary Hyperparathyroidism | renagel drug pdf | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Renagel across BioPortfolio, or for Renagel Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
